Vertex Pharmaceuticals Inc / Ma Cash Flow Statement

Cash Flow Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -0.64B-0.75B0.04B-0.14B-0.18B-0.00B-0.59B-0.08B0.09B2.09B1.18B2.71B2.34B3.32B3.62B-0.54B
Depreciation and Depletion 0.03B0.03B0.03B0.04B0.05B0.06B0.06B0.06B0.06B0.07B0.11B0.11B0.13B0.15B0.17B0.16B
Share-based Compensation 0.09B0.09B0.12B0.11B0.13B0.18B0.23B0.24B0.29B0.33B0.36B0.43B0.44B0.49B0.58B0.70B
Deferred Taxes -0.00B-0.01B0.04B-0.29B0.00B0.00B0.02B-0.12B-1.51B0.17B0.28B-0.15B-0.28B-0.54B-0.35B
Gains from Sales and Divestitures 0.00B0.00B
Gains from Investment Securities 0.02B0.02B0.02B0.03B-0.06B0.01B0.02B-0.01B-0.08B-0.03B0.04B0.20B0.48B1.06B1.68B1.08B
Asset Writedowns and Impairment 0.01B0.00B0.11B0.13B0.01B0.00B0.00B0.26B0.03B
Cash from Restructuring -0.00B-0.00B-0.00B-0.00B0.01B0.02B-0.03B-0.01B-0.01B
Non-cash Items 0.01B0.06B
Cash from Operations -0.43B-0.64B0.14B0.27B-0.06B-0.57B-0.37B0.24B0.84B1.27B1.57B3.25B2.64B4.13B3.54B-0.49B
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.00B0.01B0.02B
Depreciation & Amortization (CF) 0.03B0.03B0.04B0.04B0.05B0.06B0.06B0.06B0.06B0.07B0.11B0.11B0.13B0.15B0.18B0.21B
Change in Working Capital
Change in Receivables -0.01B0.00B0.17B-0.04B-0.05B-0.01B0.11B0.04B0.07B0.11B0.23B0.22B0.27B0.36B0.08B0.10B
Change in Inventory 0.11B0.03B-0.01B0.02B0.02B0.02B0.05B0.03B0.06B0.13B0.09B0.14B0.32B0.52B
Change in Account Payables -0.02B-0.00B0.04B0.01B-0.05B0.03B-0.00B-0.01B0.01B0.04B-0.02B0.05B0.03B0.12B0.05B0.05B
Change in Accured Expenses 0.01B0.01B0.12B0.03B0.03B-0.06B0.10B-0.01B0.26B0.30B0.17B0.43B0.31B0.54B0.43B0.21B
Change in Taxes 0.01B-0.01B
Other Working Capital Changes 0.05B0.00B-0.07B-0.04B-0.05B-0.03B-0.02B0.07B0.11B-0.02B-0.04B0.30B0.09B0.33B0.55B0.20B
Investing Activities
Capital Expenditures 0.02B0.04B0.03B0.07B0.05B0.05B0.05B0.06B0.10B0.10B0.08B0.26B0.23B0.20B0.20B0.30B
Change in Intangibles 0.06B0.01B0.08B0.06B0.19B
Acquisitions 0.09B1.15B0.30B
Change in Acquisitions & Divestments 0.79B1.28B1.02B1.37B2.35B1.56B1.07B0.76B0.37B0.43B0.48B0.44B0.50B0.92B0.84B4.47B
Cash from Investing Activities -0.51B0.01B0.21B-0.43B-0.11B0.08B0.27B0.05B-0.48B-0.20B-1.24B0.10B-0.34B-0.32B-3.14B-3.77B
Financing Activities
Other financing activities 0.00B-0.02B-0.00B0.00B0.00B0.00B0.00B-0.00B0.01B0.00B0.00B0.01B
Cash from Financing Activities 1.00B0.43B-0.12B0.17B0.25B0.55B0.19B0.13B0.07B-0.07B0.13B-0.51B-1.48B-0.07B-0.56B-1.49B
Additional items
Exchange Rate Effect -0.01B-0.00B0.00B-0.00B0.00B-0.00B-0.00B-0.00B0.01B-0.01B0.00B0.02B-0.01B-0.03B0.03B-0.04B
Change in Cash 0.06B-0.20B0.23B0.01B0.08B0.06B0.09B0.42B0.44B0.99B0.46B2.87B0.81B3.71B-0.14B-5.80B
Beginning Cash Balance 0.39B0.45B0.24B0.48B0.49B0.57B0.63B0.77B1.23B1.66B2.65B3.12B5.98B6.79B10.51B10.37B
Free Cash Flow -0.45B-0.67B0.11B0.20B-0.11B-0.62B-0.41B0.18B0.75B1.17B1.49B2.99B2.41B3.93B3.34B-0.79B
Net Cash Flow 0.06B-0.20B0.23B0.01B0.08B0.06B0.09B0.42B0.43B1.00B0.46B2.85B0.82B3.74B-0.17B-5.76B